Pending announcements Q3 and Q4, page-43

I have Monday September 19 / Tuesday 20th Australian time as the next uptick. This should be the day if FDA filling for SB. Then the clock starts. It was a smart move to do the cap raise now. There are impending milestone payments for SB coming up and possible manufacturing set up costs. Lock in the money now to continue with development of SB independent of trial results. We have 1 year for approval of SB and then I think there is a strong possibility of a buyout. Go back and read the Qbrexa deal. Botanix will have multiple other drugs in pipeline as well and permetrex licence. The company would likely be ripe for the picking by then. All long term holders are waiting for this point. Small pips are not what we are here for. Vince sells companies for $billions let’s repeat that formula with BOT.